Nicholas Blake-Knox
Managing Partner
Ireland
key takeaways
On 17 November 2026, the Central Bank of Ireland (Central Bank) published CP175 - Consultation Paper on Amendments to the List of Pre–Approval Controlled Functions (CP175). CP175 proposes a substantial overhaul of the list of Pre-Approval Controlled Functions (PCFs) in Schedule 2 of the Central Bank Reform Act, 2010 (Sections 20 and 22) Regulations, 2011, as amended (F&P Regulations). The key takeaways for regulated fund service providers (RFSPs) in the funds and asset management sector are:
CP175 implements a recommendation of the 2024 Enria Report on the F&P regime, continuing work to simplify the broader regulatory framework, reduce regulatory complexity and administrative burden for firms, while providing additional clarity on firms' responsibilities. It is the second major phase of the Central Bank's PCF review, following revised guidance resulting from CP160 in 2025. The current list of 57 sector-specific roles would be replaced by a revised list of PCF roles. Pre-approval would be reserved for roles that are responsible for leading an RFSP's culture, strategy and direction, roles required by other regulation, and roles significant to safety and soundness and to investor protection.
Removal of PCF-39A to PCF-39F
The six Designated Person roles would be removed from the PCF list, along with the mandatory requirement on FMCs to appoint them. These roles cover capital and financial management, operational risk, fund risk, investment management, distribution and regulatory compliance. The Central Bank states that this removal does not impact the regulatory obligations of FMCs.
A minimum executive management team
Under the proposed approach, all FMCs would appoint at least a Chief Executive (PCF-8), a Chief Risk Officer (PCF-14) and a Head of Investment/Chief Investment Officer. The Head of Investment/CIO is a new cross-sectoral PCF merging the current PCF-19 and PCF-30 roles. The executive team requirement will be consulted on separately as part of the Central Bank's forthcoming review of the FMC framework. That review will focus on ensuring that FMCs retain sufficient substance, expertise and oversight of delegated activities.
Other changes relevant to the funds and asset management sector
Roles no longer subject to pre-approval as PCFs will remain CF-1 roles, i.e. a controlled function exercising significant influence on the affairs of an RFSP. In practice, RFSPs will still be required to:
The legal status of the F&P Standards and the Guidance on the Standards of F&P is unchanged. Where appropriate, the Central Bank has also indicated it will further update the related F&P Guidance to reflect changes to the PCF list, once implemented, to ensure clarity regarding the Central Bank’s expectations in relation to the roles captured. The Central Bank has signalled that it will continue to use its full supervisory toolkit, including enforcement, to ensure RFSPs take responsibility for these matters.
Pending implementation, the existing F&P Regulations and the SEAR Regulations continue to apply in full. Section 23 of the Central Bank Reform Act 2010 still prohibits PCF appointments, including Designated Persons, without the Central Bank's prior written consent. Existing approvals and pending applications for retained roles are not expected to be affected.
The consultation closes on 17 February 2027, and a CP175 Feedback Statement is expected in Q2 2027. Once finalised, the changes to the F&P Regulations will take effect in line with the outcome of the three-year review of the IAF, on which the Central Bank will consult separately in early 2027.
CP175, together with the forthcoming review of the FMC framework, signals a potentially significant shift for Irish FMCs towards an executive-led model, rather than a relaxation of substance expectations. A shorter PCF list and the end of the six-role Designated Person model should reduce the administrative burden associated with the pre-approval process.In preparation for the final rules, existing FMCs should assess how current Designated Person responsibilities would sit within the proposed CEO, CRO and Head of Investment/CIO executive structure.
CP175 provides FMCs with an opportunity to influence how the move from Designated Persons to an executive team within an FMC will work, particularly for smaller and mid-sized managers.
RFSPs should continue to seek pre-approval for PCF appointments until the revised regulations take effect.
If you would like to discuss the potential implications of CP175 for your governance arrangements, or require assistance preparing a consultation response, please speak to your usual Walkers contact or one of the contacts below:
Authors
Key contacts
Managing Partner
Ireland
Senior Associate
Ireland